Published on April 14th, 2017 | by itadmin
Rockwell Medical Sees Higher-Than-Expected Losses for Q4
Rockwell Medical Inc (RMTI) recently posted their financial results for the fourth quarter of the 2017 fiscal year. The company incurred losses for the quarter that were higher than expected, though their sales did beat market expectations slightly.
The company that produces dialysis kits and is based in Wixom, Michigan didn’t trade after-hours, but they did close out the previous day of trading at $11.13, which represents an increase of 4 percent.
Rockwell Medical saw their net loss declined to $6.38 million, which equates to a loss per share of $0.14, from $8.33 million during the same quarter of the previous year, which equated to $0.21 per share.
The company saw their sales climb from $13.9 million in the same quarter of the previous year to $14.4 million. The market and analysts were expecting a loss of $0.09 per share, with revenues coming in at $13.2 million. Rockwell didn’t offer guidance for earnings right away.
Rockwell has been trading between $8.1 and $14.8 over the past 52 weeks. The company has a market cap of $475.15 million.